Coronavirus (COVID-19)
Learn more
January 06, 2017
Location: Hartford Hospital's Institute of Living
The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a clinical trial testing the safety and efficacy of Lurasidone treatment study in pediatric and adolescent depression associated with Bipolar I Disorder. All subjects who complete the 6-week study are eligible for a 104 week open-label flexible-dose trial of Lurasidone. For more information about this trial, please contact: Dr. Salma Malik Phone: 860.545.7502 Email: clinical.trials@hhchealth.org
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.